Table 2.
Compound | Cell line | T/C Value
|
||||||
---|---|---|---|---|---|---|---|---|
3 × 10−11 M | 10−10 M | 3 × 10−10 M | 10−9 M | 3 × 10−8 M | 10−7 M | 3 × 10−7 M | ||
Analogs with DOX | ||||||||
AN-253 | CFPAC-1 | 79 (32) | 18 (−7) | 6 (−7) | ||||
DMS-53 | 67 (−12) | 33 (−15) | 6 (−15) | |||||
AN-246 | CFPAC-1 | 89 | 28 | 6 | ||||
DMS-53 | 70 | 23 | 2 | |||||
AN-161 | CFPAC-1 | 95 | 35 | 10 | ||||
DMS-53 | 80 | 39 | 5 | |||||
AN-160 | CFPAC-1 | 85 | 22 | 0 | ||||
DMS-53 | 68 | 24 | 0 | |||||
AN-251 | CFPAC-1 | 88 | 26 | −2 | ||||
DMS-53 | 60 | 3 | −12 | |||||
DOX | CFPAC-1 | 68 | 22 | 4 | ||||
DMS-53 | 78 | 27 | 1 | |||||
Analogs with AN-201 | ||||||||
AN-254 | CFPAC-1 | 95 | 13 | −7 | ||||
DMS-53 | 45 | −6 | −15 | |||||
AN-247 | CFPAC-1 | 90 | 27 | −7 | ||||
DMS-53 | 61 | 4 | −14 | |||||
AN-257 | CFPAC-1 | 85 | 16 | −7 | ||||
DMS-53 | 58 | 0 | −18 | |||||
AN-215 | CFPAC-1 | 97 | 42 | −7 | ||||
DMS-53 | 52 | 2 | −15 | |||||
AN-252 | CFPAC-1 | 91 | 56 | −6 | ||||
DMS-53 | 72 | 13 | −19 | |||||
AN-201 | CFPAC-1 | 76 | 8 | −5 | ||||
DMS-53 | 34 | −7 | −19 |
CFPAC-1 cells were incubated in Iscove’s modified Dulbecco’s medium with 10% fetal bovine serum (FBS) for 120 hr and DMS-53 cells were incubated for 140 hr in Waymouth’s MB 752/1 medium containing 10% FBS in 96-well plates. Relative cell number in treated and control plates was determined by crystal violet staining and expressed as T/C values where T/C = (T − C0)/(C − C0) × 100. [T = absorbance of treated cultures, C = absorbance of control cultures, C0 = absorbance of cultures at the start of incubation (t = 0). Measured absorbance is proportionate to cell number.] Negative T/C values indicate a cell number smaller than the number originally seeded at t = 0—i.e., a cytocidal effect. The structures of the compounds are shown in Table 1. The carrier peptides had no effect on cell proliferation at 10−7 M and lower concentrations. T/C values in brackets are derived from results with a sample of AN-253 containing decomposition products.